272 related articles for article (PubMed ID: 22384081)
21. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
22. Wnt5a: its signalling, functions and implication in diseases.
Kikuchi A; Yamamoto H; Sato A; Matsumoto S
Acta Physiol (Oxf); 2012 Jan; 204(1):17-33. PubMed ID: 21518267
[TBL] [Abstract][Full Text] [Related]
23. Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2.
Masckauchán TN; Agalliu D; Vorontchikhina M; Ahn A; Parmalee NL; Li CM; Khoo A; Tycko B; Brown AM; Kitajewski J
Mol Biol Cell; 2006 Dec; 17(12):5163-72. PubMed ID: 17035633
[TBL] [Abstract][Full Text] [Related]
24. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
[TBL] [Abstract][Full Text] [Related]
25. Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3.
Basu M; Roy SS
J Biol Chem; 2013 Feb; 288(6):4355-67. PubMed ID: 23250740
[TBL] [Abstract][Full Text] [Related]
26. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
[TBL] [Abstract][Full Text] [Related]
27. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
[TBL] [Abstract][Full Text] [Related]
28. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
29. Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT.
Bisson JA; Mills B; Paul Helt JC; Zwaka TP; Cohen ED
Dev Biol; 2015 Feb; 398(1):80-96. PubMed ID: 25482987
[TBL] [Abstract][Full Text] [Related]
30. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
31. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer.
Wang Q; Symes AJ; Kane CA; Freeman A; Nariculam J; Munson P; Thrasivoulou C; Masters JR; Ahmed A
PLoS One; 2010 May; 5(5):e10456. PubMed ID: 20454608
[TBL] [Abstract][Full Text] [Related]
32. Wnt5a regulates distinct signalling pathways by binding to Frizzled2.
Sato A; Yamamoto H; Sakane H; Koyama H; Kikuchi A
EMBO J; 2010 Jan; 29(1):41-54. PubMed ID: 19910923
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic effects of WNT5A in Epstein-Barr virus‑associated nasopharyngeal carcinoma.
Yap LF; Ahmad M; Zabidi MM; Chu TL; Chai SJ; Lee HM; Lim PV; Wei W; Dawson C; Teo SH; Khoo AS
Int J Oncol; 2014 May; 44(5):1774-80. PubMed ID: 24626628
[TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic protein-2 modulates Wnt and frizzled expression and enhances the canonical pathway of Wnt signaling in normal keratinocytes.
Yang L; Yamasaki K; Shirakata Y; Dai X; Tokumaru S; Yahata Y; Tohyama M; Hanakawa Y; Sayama K; Hashimoto K
J Dermatol Sci; 2006 May; 42(2):111-9. PubMed ID: 16442268
[TBL] [Abstract][Full Text] [Related]
35. WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism.
Sherwood V; Chaurasiya SK; Ekström EJ; Guilmain W; Liu Q; Koeck T; Brown K; Hansson K; Agnarsdóttir M; Bergqvist M; Jirström K; Ponten F; James P; Andersson T
Carcinogenesis; 2014 Apr; 35(4):784-94. PubMed ID: 24293407
[TBL] [Abstract][Full Text] [Related]
36. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
[TBL] [Abstract][Full Text] [Related]
37. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
[TBL] [Abstract][Full Text] [Related]
38. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
[TBL] [Abstract][Full Text] [Related]
39. Lack of Wnt5A expression in Merkel cell carcinoma.
Weeraratna AT; Houben R; O'Connell MP; Becker JC
Arch Dermatol; 2010 Jan; 146(1):88-9. PubMed ID: 20083703
[No Abstract] [Full Text] [Related]
40. WNT5A encodes two isoforms with distinct functions in cancers.
Bauer M; Bénard J; Gaasterland T; Willert K; Cappellen D
PLoS One; 2013; 8(11):e80526. PubMed ID: 24260410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
